Abstract
Breast cancer is the most common malignancy of women in North America and is the leading cause of death in women between the ages of 40 and 55. In 1995 approximately 182 000 women in the United States will have been diagnosed with breast cancer, and 46 000 women will die of this disease [20].
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Adler LP, Crowe JP, Al-Kaisi NK, Sunshine JL (1993) Evaluation of breast masses and axillary lymph nodes with F-18 2-deoxy-2-fluoro-D-glucose PET. Radiology 187:743–750
Balon HR, Fink-Bennett D, Stoffer SS (1992) Tc-99m sestamibi uptake by recurrent Hunthle cell carcinoma of the thyroid. J Nucl Med 33:1393–1395
Bassa P, Kim EE, Inoue T, Wiong FCL, Korkmaz M, Yang DJ, Wong W-H, Hicks KW, Buzdar AU, Podoloff DA (1996) Evaluation of preoperative chemotherapy using PET with F-18 fluorodeoxyglucose in breast cancer. J Nucl Med 37:931–938
Bird R, Wallace T, Yankaskas B (1992) Analysis of cancers missed at screening mammography. Radiology 184:613–617
Boetes C, Mus RDM, Holland R, Barentsz JO, Strijk SP, Wobbes T, Hendriks JHCL, Ruys SHJ (1995) Breast tumors: comparative accuracy of MR imaging relative to mammography and US for demonstrating extent. Radiology 197:743–747
Dehdashti F, Mortimer JE, Siegel BA, Griffieth LK, Bonasera TJ, Fusselman MJ, Detert DD, Cutler D, Katzenellenbogan JA, Welch MJ (1995) Positron tomographic assessment of estrogen receptors in breast cancer: comparison with FDG-PET and in vitro receptor assays. J Nucl Med 36:1766–1774
Harms SE, Flaming DP, Hesley KL (1993) MR imaging of the breast with rotating delivery of excitation off resonance: clinical experience with pathologic correlation. Radiology 187:493–501
Hawkins RA, Hoh C, Dahlbom M (1991) PET cancer evaluation with FDG. J Nucl Med 32:1555–1558
Inoue T, Kim EE, Wallace S, Yang DJ, Wong FCL, Bassa P, Cherif A, Delpassand E, Buzdar A, Podoloff DA (1996) PET using F-18 fluorotamoxifen to evaluate therapeutic responses in patients with breast cancer. Cancer Biotherapy Radiopharm 11:235–245
Jackson V (1990) The role of US in breast imaging. Radiology 177:305–311
Khalkhali I, Cutrone JA, Mena IG, Diggles IE, Venegas RJ, Vargas HI, Jackson BL, Khalkhali S, Moss JF, Klein SR (1995) Scintimammography: the complementary role of Tc-99m sestamibi prone breast imaging for the diagnosis of breast carcinoma. Radiology 196:421–426
Kopans DB (1992) The positive predictive value of mammography. AJR 158:521–526
Maublant J, de Latour M, Mestas D, Clemenson A, Charrier S, Feillel V (1996) Tc-99m sestamibi uptake in breast tumor and associated lymph nodes. J Nucl Med 37:922–925
McLean RG, Ege GN (1986) Prognostic value of axillary lymphoscintigraphy in breast cancer patients. J Nucl Med 27:1116–1124
Piccolo S, Lastoria S, Mainolfi C, Muto P, Bazzicalupo L, Salvatore M (1995) Tc-99m methylene diphosphonate scintimammography to image primary breast cancer. J Nucl Med 36:718–724
Taillefer R, Robidoux A, Lambert R, Turpin S, Laperriere J (1995) Tc-99m sestamibi prone scintimammography to detect primary breast cancer and axillary lymph node involvement. J Nucl Med 36:1758–1765
Uren RF Howman-Giles RB, Thompson JF, Malouf D, Ramsey-Stewart G, Niesche FW, Renwick SB (1995) Mammary lymphoscintigraphy in breast cancer. J Nucl Med 36:1775–1780
Wahl RL, Cody R, Fisher S (1991) FDG uptake before and after estrogen receptor stimulation: feasibility studies for functional receptor imaging. J Nucl Med 32:1011–1015
Waxman AD, Ramanna L, Memsic LD (1993) Thallium scintigraphy in the evaluation of mass abnormalities of the breast. J Nucl Med 34:18–23
Wingo PA, Tong T, Bolden S (1995) Cancer statistics. Cancer 5:8–30
Worsley DF, Lentle BC (1993) Uptake ofi Tc-99m MDP in primary amyloidosis with a review of the mechanisms of soft-tissue localization of bone-seeking radiopharmaceuticals. J Nucl Med 34:1612–1615
Rights and permissions
Copyright information
© 1998 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Kim, E.E. (1998). Breast Cancer. In: Nuclear Imaging of the Chest. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-80387-1_15
Download citation
DOI: https://doi.org/10.1007/978-3-642-80387-1_15
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-80389-5
Online ISBN: 978-3-642-80387-1
eBook Packages: Springer Book Archive